$2.7399
0.0199[0.73%]
Last update: 12:10PM Get Real Time Here
Arbutus Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Arbutus Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/02/2024 | AM | ABUS | Q1 | -$0.10 | -$0.11 | — | — | $6.69M | $2.15M | — | — | Get Alert |
02/29/2024 | AM | ABUS | Q4 | -$0.14 | -$0.12 | -$0.12 | 0.00% | $6.25M | $4.79M | $2.15M | -55.22% | Get Alert |
11/07/2023 | AM | ABUS | Q3 | -$0.12 | -$0.11 | -$0.12 | -9.09% | $5.95M | $4.75M | $4.66M | -1.94% | Get Alert |
08/03/2023 | AM | ABUS | Q2 | -$0.10 | -$0.12 | -$0.10 | 16.67% | $14.24M | $5.02M | $4.65M | -7.35% | Get Alert |
05/04/2023 | AM | ABUS | Q1 | -$0.11 | -$0.14 | -$0.10 | 28.57% | $12.58M | $6.03M | $6.69M | 10.90% | Get Alert |
03/02/2023 | AM | ABUS | Q4 | -$0.15 | -$0.13 | -$0.14 | -7.69% | $3.21M | $6.17M | $6.25M | 1.22% | Get Alert |
11/09/2022 | AM | ABUS | Q3 | -$0.24 | -$0.13 | -$0.12 | 7.69% | $3.34M | $9.37M | $5.95M | -36.48% | Get Alert |
08/04/2022 | AM | ABUS | Q2 | -$0.23 | -$0.13 | -$0.10 | 23.08% | $2.33M | $6.77M | $14.24M | 110.35% | Get Alert |
05/05/2022 | AM | ABUS | Q1 | -$0.21 | -$0.16 | -$0.11 | 31.25% | $2.11M | $4.37M | $12.58M | 187.89% | Get Alert |
03/03/2022 | AM | ABUS | Q4 | -$0.23 | -$0.19 | -$0.15 | 21.05% | $2.39M | $2.87M | $3.21M | 11.71% | Get Alert |
11/04/2021 | AM | ABUS | Q3 | -$0.27 | -$0.24 | -$0.24 | 0.00% | $1.52M | $2.38M | $3.34M | 40.34% | Get Alert |
08/05/2021 | AM | ABUS | Q2 | -$0.25 | -$0.22 | -$0.23 | -4.55% | $1.51M | $2.12M | $2.33M | 9.86% | Get Alert |
05/05/2021 | AM | ABUS | Q1 | -$0.25 | -$0.23 | -$0.21 | 8.70% | $1.49M | $3.31M | $2.11M | -36.16% | Get Alert |
03/04/2021 | AM | ABUS | Q4 | -$0.46 | -$0.22 | -$0.23 | -4.55% | $1.62M | $1.96M | $2.39M | 21.73% | Get Alert |
11/05/2020 | AM | ABUS | Q3 | -$0.73 | -$0.22 | -$0.27 | -22.73% | $3.10M | $1.66M | $1.52M | -8.25% | Get Alert |
08/07/2020 | AM | ABUS | Q2 | -$0.46 | -$0.24 | -$0.25 | -4.17% | $700.00K | $1.74M | $1.51M | -12.99% | Get Alert |
05/11/2020 | AM | ABUS | Q1 | -$0.47 | -$0.39 | -$0.25 | 35.90% | $700.00K | $220.00K | $1.49M | 577.73% | Get Alert |
03/05/2020 | AM | ABUS | Q4 | -$0.37 | -$0.39 | -$0.46 | -17.95% | $1.60M | $220.00K | $1.62M | 635.45% | Get Alert |
11/06/2019 | AM | ABUS | Q3 | -$0.30 | — | -$0.73 | — | $1.60M | — | $3.10M | — | Get Alert |
Arbutus Biopharma (ABUS) is scheduled to report earnings on May 2, 2024. The last reported earnings were for reported on February 29, 2024 for Q4.
The Actual EPS was $-0.12, which hit the estimate of $-0.12.
The Actual Revenue was $2.1M, which missed the estimate of $4.8M.
Browse earnings estimates, EPS, and revenue on all stocks.